The company's financial position is characterized by a substantial $1.7 billion accumulated deficit and a shrinking asset base, which declined from $831.7 million in 2023Q4 to $645.8 million by 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Aug'98 | Aug'97 | Aug'96 |
|---|
| Total Current Assets | 626.02M | 649.88M | 595.4M | 724.98M | 689.1M | 878.73M | 879.23M | 855M | 378M | 153.27M | 146.33M | 143.52M | 145.28M | 219.4M | 285.69M | 118.97M | 33.11M | 56.05M | 16.14M | 21.73M | 39.59M | 36.67M | 12.99M | 14.6M | 47.64M | 41.62M | 24.56M | 12.07M | 6.3M | 22.3M | 20.9M |
| Cash & Short-Term Investments | 307.82M | 302.79M | 294.22M | 320.66M | 309.36M | 454.13M | 500.93M | 644.59M | 249.23M | 73.64M | 98.25M | 106.96M | 119.54M | 191.51M | 260.24M | 116.6M | 31.44M | 52.26M | 11.24M | 18.3M | 36.8M | 33.91M | 10.99M | 2.1M | 24.29M | 30.19M | 2.02M | 1.61M | 800K | 5.6M | 4.8M |
| Cash Only | 131.06M | 134.86M | 121.04M | 199.25M | 217.67M | 219.45M | 186.96M | 644.59M | 249.23M | 73.64M | 98.25M | 106.96M | 119.54M | 191.51M | 260.24M | 116.6M | 31.44M | 52.26M | 11.24M | 18.3M | 36.8M | 33.91M | 10.99M | 2.1M | 24.29M | 30.13M | 2.02M | 1.61M | 800K | 5.6M | 4.8M |
| Short-Term Investments | 176.76M | 167.93M | 173.18M | 121.41M | 91.69M | 234.67M | 313.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 108.05M | 126.83M | 122.28M | 133.56M | 130.99M | 163.65M | 154.57M | 116.43M | 66.52M | 45.32M | 19.98M | 13.83M | 7.84M | 3.65M | 0 | 0 | 0 | 1.19M | 674K | 1.7M | 1.62M | 2.08M | 1.31M | 1.33M | 14.52M | 7.22M | 4.34M | 6.9M | 3.6M | 7.4M | 14.8M |
| Days Sales Outstanding | 204.39 | 216.68 | 195.23 | 158.84 | 129.5 | 102.43 | 91.88 | 98.89 | 105.93 | 91.33 | 56.08 | 61.73 | 52.81 | 50.49 | - | - | - | - | - | 84.45 | 1.18K | 1.52K | 471.95 | 66.11 | 80.9 | 528.02 | 100.77 | 224.47 | 131.4 | 111.15 | 251.26 |
| Inventory | 183.59M | 195.91M | 166.05M | 258.62M | 228.73M | 234.68M | 188.86M | 76.77M | 57.8M | 30.26M | 20.51M | 18.98M | 13.73M | 21.21M | 21.26M | 0 | 0 | 0 | 0 | 881K | 414K | 0 | 0 | 2.65M | 7.73M | 3.55M | 2.81M | 3.41M | 1.1M | 1.3M | 1.4M |
| Days Inventory Outstanding | 657.21 | 770.73 | 411.65 | 667.71 | 658.89 | 706 | 524.45 | 291.82 | 386.81 | 245.7 | 217.82 | 248.59 | 244.69 | 649.87 | 17.19K | - | - | - | - | - | - | - | - | 81.23 | 93.69 | 60.39 | 221.89 | 418.6 | 108.51 | 169.46 | 127.75 |
| Other Current Assets | 26.56M | 24.35M | 12.85M | 525K | 20.02M | 3.92M | 3.92M | 3.91M | 1.5M | 600K | 600K | 600K | 1.53M | 3.03M | 4.19M | 2.37M | 1.67M | 2.6M | 4.23M | 840K | 42K | 0 | 0 | 7.5M | 0 | 0 | 15.05M | 150K | 800K | 8M | -100K |
| Total Non-Current Assets | 19.75M | 20.89M | 89.95M | 106.7M | 197.08M | 189.34M | 86.79M | 27.2M | 7.72M | 8.33M | 20.67M | 29.94M | 25.83M | 33.07M | 25.16M | 7.41M | 2.25M | 145K | 20.52M | 20.53M | 9.23M | 10.09M | 10.73M | 32.78M | 49.89M | 49.38M | 24.04M | 21.68M | 10.2M | 17.9M | 24M |
| Property, Plant & Equipment | 6.01M | 6.47M | 7.61M | 8.42M | 9.95M | 9.09M | 10.07M | 10.87M | 63K | 28K | 78K | 243K | 381K | 579K | 811K | 432K | 88K | 128K | 595K | 595K | 282K | 460K | 427K | 1.03M | 2.39M | 2.23M | 1.44M | 1.63M | 6.2M | 9.1M | 6.3M |
| Fixed Asset Turnover | 31.44x | 33.01x | 30.05x | 36.43x | 37.11x | 64.19x | 60.98x | 39.53x | 3638.32x | 6468.00x | 1667.74x | 336.44x | 142.26x | 45.51x | - | - | - | - | - | 12.38x | 1.77x | 1.09x | 2.38x | 7.14x | 27.43x | 2.24x | 10.97x | 6.89x | 1.61x | 2.67x | 3.41x |
| Goodwill | 0 | 13.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 12.73M | 0 | 16.39M | 19.3M | 21.78M | 23.55M | 13.82M | 15.26M | 7.48M | 8.13M | 8.77M | 9.42M | 10.06M | 10.71M | 11.36M | 0 | 0 | 0 | 19.92M | 19.92M | 8.95M | 9.63M | 10.3M | 31.75M | 47.5M | 47.15M | 22.61M | 20.06M | 4M | 8.7M | 9.2M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 1.27M | 35M | 62.47M | 0 | 0 | -1.74M | 0 | 0 | 200K | 3.3M | 3.3M | 0 | 0 | 17K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.01M | 1.05M | 65.95M | 78.97M | 164.08M | 121.71M | 432K | 1.07M | 174K | 174K | 741K | 2.04M | 2.63M | 6.54M | 1.65M | 6.44M | 0 | 0 | 0 | 15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 8.5M |
| Total Assets | 645.76M | 670.77M | 685.35M | 831.68M | 886.18M | 1.07B | 966.02M | 882.21M | 385.71M | 161.6M | 167M | 173.46M | 171.11M | 252.48M | 310.86M | 126.38M | 35.37M | 56.2M | 36.66M | 42.25M | 48.83M | 46.76M | 23.72M | 47.38M | 97.53M | 90.99M | 48.6M | 33.75M | 16.5M | 40.2M | 44.9M |
| Asset Turnover | 0.32x | 0.32x | 0.33x | 0.37x | 0.42x | 0.55x | 0.64x | 0.49x | 0.59x | 1.12x | 0.78x | 0.47x | 0.32x | 0.10x | - | - | - | - | - | 0.17x | 0.01x | 0.01x | 0.04x | 0.16x | 0.67x | 0.05x | 0.32x | 0.33x | 0.61x | 0.60x | 0.48x |
| Asset Growth % | -31.95% | -2.13% | -17.59% | -6.15% | -17.03% | 10.56% | 9.5% | 128.72% | 138.69% | -3.23% | -3.73% | 1.38% | -32.23% | -18.78% | 145.97% | 257.34% | -37.07% | 53.3% | -13.25% | -13.46% | 4.42% | 97.12% | -49.93% | -51.43% | 7.19% | 87.24% | 43.98% | 104.56% | -58.96% | -10.47% | 26.12% |
| Total Current Liabilities | 179.64M | 194.46M | 179.95M | 259.28M | 259.48M | 370.68M | 307.44M | 242.25M | 157.26M | 108.53M | 76.25M | 50.72M | 40.31M | 37.54M | 25.2M | 8.45M | 7.58M | 6.69M | 7.11M | 15.41M | 10.76M | 8M | 4.34M | 53.73M | 66.97M | 53.74M | 4.54M | 20.05M | 21.2M | 23.1M | 8.1M |
| Accounts Payable | 48.15M | 45.35M | 40.37M | 52.76M | 64.6M | 114.92M | 105.88M | 49.95M | 37.63M | 25.16M | 6.06M | 10.83M | 8.53M | 6.38M | 17.46M | 4.42M | 4.45M | 2.46M | 1.96M | 3.46M | 2.1M | 779K | 1.09M | 3.56M | 3.07M | 3.02M | 1.83M | 3.57M | 8.4M | 2.9M | 2M |
| Days Payables Outstanding | 156.32 | 178.43 | 100.07 | 136.22 | 186.09 | 345.73 | 294 | 189.88 | 251.83 | 204.25 | 64.39 | 141.84 | 151.9 | 195.34 | 14.12K | 16.06K | 16.24K | 1.54K | - | - | - | - | 3.71K | 109.21 | 37.23 | 51.41 | 144.85 | 437.98 | 828.65 | 378.04 | 182.5 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.13M | 34.24M | 22.83M | 31.3M | 14.74M | 15.39M | 12.97M | 0 | 0 | 0 | 0 | 1.04M | 10K | 0 | 11K | 0 | 31.5M | 27.55M | 45.34M | 248K | 9.14M | 7.6M | 12.7M | 200K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 2.34M | 2.2M | 2.65M | 2.93M | 2.34M | 1.22M | 1.64M | 1.17M | 923K | 16.27M | 1.7M | 0 | 0 | 0 | 0 | 0 | 6.34M | 0 | 6.27M | 0 | 13.65M | 9.48M | 1.88M | 1.04M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 131.49M | 149.1M | 139.58M | 185.23M | 35.64M | 45.6M | 28.79M | 16.59M | 72M | 5.16M | 5.8M | 4.28M | 2.25M | 10.24M | 3.16M | 1.78M | 0 | 986.01K | 334K | 5.6M | 444K | 943K | 541K | 5.01M | 26.87M | 3.5M | 1.42M | 7.34M | 5.2M | 7.5M | 5.9M |
| Current Ratio | 3.48x | 3.34x | 3.31x | 2.80x | 2.66x | 2.37x | 2.86x | 3.53x | 2.40x | 1.41x | 1.92x | 2.83x | 3.60x | 5.84x | 11.34x | 14.08x | 4.37x | 8.37x | 2.27x | 1.41x | 3.68x | 4.58x | 2.99x | 0.27x | 0.71x | 0.77x | 5.41x | 0.60x | 0.30x | 0.97x | 2.58x |
| Quick Ratio | 2.46x | 2.33x | 2.39x | 1.80x | 1.77x | 1.74x | 2.25x | 3.21x | 2.04x | 1.13x | 1.65x | 2.46x | 3.26x | 5.28x | 10.49x | 14.08x | 4.37x | 8.37x | 2.27x | 1.35x | 3.64x | 4.58x | 2.99x | 0.22x | 0.60x | 0.71x | 4.79x | 0.43x | 0.25x | 0.91x | 2.41x |
| Cash Conversion Cycle | 705.28 | 808.99 | 506.8 | 690.33 | 602.3 | 462.69 | 322.32 | 200.83 | 240.91 | 132.79 | 209.51 | 168.48 | 145.6 | 505.02 | - | - | - | - | - | - | - | - | - | 38.14 | 137.37 | 537 | 177.82 | 205.09 | -588.74 | -97.42 | 196.51 |
| Total Non-Current Liabilities | 16.71M | 17.03M | 19.22M | 20.31M | 31.37M | 30.28M | 31.07M | 31.7M | 76.12M | 118.17M | 99.81M | 251.93M | 219.25M | 248.79M | 289.65M | 123.89M | 230.16M | 902K | 651K | 2.69M | 235K | 180K | 2.69M | 35.06M | 36.78M | 7.59M | 12.89M | 1.52M | 8.8M | 2.4M | 13.5M |
| Long-Term Debt | 5.58M | 6.08M | 0 | 0 | 0 | 0 | 0 | 0 | 46.11M | 99.83M | 85.16M | 230.12M | 211.46M | 237.03M | 233.98M | 0 | 0 | 0 | 0 | 2.05M | 0 | 14K | 2M | 0 | 21.52M | 6.62M | 9.37M | 942K | 2M | 2.2M | 13.2M |
| Capital Lease Obligations | 13.42M | 6.08M | 7.72M | 8.74M | 10.02M | 8.58M | 9.15M | 9.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 764K | 88K | 570K | 0 | 0 | 0 | 0 | 0 | 0 | 193K | 0 | 141K | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.74M | 0 | 8.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 575K | 200K | 200K | 200K |
| Other Non-Current Liabilities | 11.12M | 4.87M | 11.5M | 9.06M | 8.21M | 7.65M | 6.21M | 3.75M | 10.52M | 1.15M | 710K | 8.51M | 7.79M | 11.76M | 55.67M | 123.13M | 230.07M | 332K | 651K | 642K | 235K | 166K | 687K | 0 | 15.07M | 973K | 3.38M | 0 | 6.6M | 0 | 100K |
| Total Liabilities | 196.35M | 211.49M | 199.17M | 279.59M | 290.85M | 400.97M | 338.52M | 273.95M | 233.38M | 226.7M | 176.06M | 302.65M | 259.56M | 286.33M | 314.85M | 132.34M | 237.73M | 7.59M | 7.76M | 18.11M | 10.99M | 8.18M | 7.03M | 53.73M | 103.75M | 61.33M | 17.43M | 21.57M | 30M | 25.5M | 21.6M |
| Total Debt | 5.58M | 12.16M | 7.72M | 8.74M | 10.02M | 8.58M | 9.15M | 59.57M | 80.35M | 122.66M | 116.45M | 244.86M | 226.86M | 248.13M | 233.98M | 764K | 88K | 0 | 0 | 2.06M | 0 | 176K | 2M | 31.5M | 49.26M | 51.95M | 9.76M | 10.08M | 9.6M | 14.9M | 13.4M |
| Net Debt | -125.48M | -122.7M | -113.31M | -190.51M | -207.65M | -210.88M | -177.81M | -585.01M | -168.88M | 49.02M | 18.2M | 137.9M | 107.32M | 56.62M | -26.26M | -115.84M | -31.35M | -52.26M | -11.24M | -16.24M | -36.8M | -33.73M | -8.99M | 29.4M | 24.97M | 21.83M | 7.74M | 8.47M | 8.8M | 9.3M | 8.6M |
| Debt / Equity | 0.01x | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.10x | 0.53x | - | - | - | - | - | - | - | - | - | - | 0.09x | - | 0.00x | 0.12x | - | - | 1.75x | 0.31x | 0.83x | - | 1.01x | 0.58x |
| Debt / EBITDA | -0.16x | - | - | - | - | 0.64x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.22x | - | - | - | - | - |
| Net Debt / EBITDA | 3.65x | - | - | - | - | -15.79x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.35x | - | - | - | - | - |
| Interest Coverage | - | -5148.71x | -11027.57x | -6734.75x | -6919.33x | 88.52x | -5.67x | -2.39x | -12.09x | -4.61x | -3.07x | -4.89x | -2.20x | -3.96x | -8.44x | -66894.00x | -13158.00x | -6.77x | -9.39x | -6.01x | - | -11.16x | - | - | -1.15x | - | - | - | -0.43x | -10.13x | - |
| Total Equity | 449.41M | 459.28M | 486.18M | 552.1M | 595.33M | 667.1M | 627.5M | 608.26M | 152.33M | -65.1M | -9.06M | -129.19M | -88.45M | -33.86M | -4M | -5.96M | -202.37M | 48.6M | 28.9M | 24.15M | 37.84M | 38.58M | 16.69M | -6.35M | -6.21M | 29.67M | 31.17M | 12.18M | -13.5M | 14.7M | 23.3M |
| Equity Growth % | -40.05% | -5.53% | -11.94% | -7.26% | -10.76% | 6.31% | 3.16% | 299.31% | 333.99% | -618.7% | 92.99% | -46.06% | -161.25% | -747.04% | 32.96% | 97.05% | -516.38% | 68.18% | 19.67% | -36.17% | -1.93% | 131.11% | 362.96% | -2.16% | -120.95% | -4.82% | 155.88% | 190.23% | -191.84% | -36.91% | -19.38% |
| Book Value per Share | 21.61 | 22.13 | 23.66 | 27.09 | 29.68 | 33.15 | 32.87 | 35.52 | 10.25 | -4.81 | -0.86 | -14.30 | -10.18 | -4.05 | -0.56 | -0.92 | -40.38 | 22.91 | 26.20 | 51.55 | 94.21 | 190.94 | 120.42 | -74.20 | -133.10 | 141.75 | 740.29 | 1624.78 | -1800.00 | 1985.68 | 3286.32 |
| Total Shareholders' Equity | 449.41M | 459.28M | 486.18M | 552.1M | 595.33M | 667.1M | 627.5M | 608.26M | 152.33M | -65.1M | -9.06M | -129.19M | -88.45M | -33.86M | -4M | -5.96M | -202.37M | 48.6M | 28.9M | 24.15M | 37.84M | 38.58M | 16.69M | -6.35M | -6.21M | 29.67M | 31.17M | 12.18M | -13.5M | 14.7M | 23.3M |
| Common Stock | 314.06M | 310.18M | 305.3M | 302.76M | 299M | 294.03M | 290.12M | 269.17M | 246.66M | 208.77M | 207.17M | 149.98M | 143.11M | 141.48M | 124.6M | 113.32M | 90.47M | 83.93M | 25.93M | 12.94M | 7.99M | 6.78M | 3.21M | 29.09M | 15.85M | 11.18M | 10.19M | 3.07M | 2.5M | 0 | 0 |
| Retained Earnings | -1.72B | -1.71B | -1.67B | -1.59B | -1.53B | -1.42B | -1.43B | -1.41B | -1.39B | -1.27B | -1.2B | -1.12B | -970.23M | -913.87M | -747.64M | -568.46M | -499.33M | -271.3M | -203.77M | -185.19M | -144.43M | -119.71M | -101M | -105.66M | -84.84M | -41.57M | -37.58M | -46.03M | -50.4M | -21.9M | -12.2M |
| Treasury Stock | 0 | -67.36M | -65.33M | -63.75M | -61.77M | -60.73M | -51.08M | -35.9M | -10.41M | -4.23M | -1.51M | -411K | -217K | -217K | -217K | -217K | -217K | -217K | -217K | -217K | -217K | -217K | -217K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -816K | 0 | -754K | -588K | -400K | 0 | -200K | -115K | -2.57M | -2.44M | 49.45M | 27.63M | 27.63M | 27.63M | -977K | -1.66M | -1.5M | -1.54M | -520K | -500K | -5.4M | -1M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Single product revenue erosion
As reported in recent financial statements, Amarin's total assets have declined from $831.7 million in 2023Q4 to $645.8 million by 2026Q1, signaling a persistent contraction in the company's resource base as it navigates the erosion of its primary U.S. revenue stream and ongoing commercial restructuring.
The consistent reduction in total assets suggests that the company is consuming its capital base to fund operations rather than reinvesting for growth. This downward trajectory warrants close monitoring, as it may indicate a diminishing capacity to support long-term international expansion efforts.
Based on the latest quarterly data, Amarin maintains a cash position of $131.1 million as of 2026Q1, which, while providing a current ratio of 3.48, remains under pressure due to the company's ongoing inability to achieve consistent positive operating cash flow from its core pharmaceutical business.
While the current ratio appears superficially healthy, the lack of recurring revenue growth suggests that this liquidity buffer is finite. Investors should monitor the rate of cash depletion, as the current burn rate may necessitate further capital preservation measures or potential external financing.
According to historical balance sheet figures, Amarin's equity base has been significantly impaired by a persistent accumulated deficit of $1.7 billion, which underscores the long-term challenges the firm has faced in translating clinical success into sustainable, profitable operations for its shareholders.
The stagnation of retained earnings at this negative level suggests that the company has struggled to generate organic value, relying instead on external capital to sustain its business model. This structural weakness in the equity account highlights the high-risk nature of the current investment thesis.
As indicated by the company's reported figures, goodwill has steadily declined from $19.3 million in 2023Q4 to $12.7 million in 2026Q1, which may suggest ongoing management assessments of the carrying value of past acquisitions in light of the company's current commercial headwinds.
The gradual write-down of these intangible assets may imply that the strategic value of previous investments is being reassessed as the market environment for icosapent ethyl shifts. Further impairment charges could potentially impact the book value of equity, adding another layer of uncertainty to the balance sheet.
Quick answers to the most common questions about buying AMRN stock.
As of 2025, Amarin Corporation plc (AMRN) had total assets of $670.8M including $649.9M in current assets.
Amarin Corporation plc (AMRN) carries total debt of $12.2M, offset by $302.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Amarin Corporation plc (AMRN) has total shareholders' equity (book value) of $459.3M ($22.13 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Amarin Corporation plc (AMRN) reported a current ratio of 3.34x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.